Companies: 10,795·Total market cap: $144.5T
ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited

ASLNNASDAQHealthcare
$0.60
$-0.10(-14.27%)
Market Cap$777122375
P/E Ratio—
52W High$17.04
52W Low$0.475
Shares OutstandingFinancialsRevenue

ASLAN Pharmaceuticals Limited (ASLN) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

ASLN · shares outstanding · updated Jun 9, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
4.1M▲ +17.93% YoY Change
FY · as of Dec 31, 2023 · Reported in USD
vs 3.5M in FY 2022
Diluted Shares Outstanding
4.1M
incl. options, RSUs, convertibles
Dilution Spread
+0.00%
Diluted vs Basic
YoY Change
+17.93%
year-over-year
Float (Free Float)
102.6M
publicly tradable shares
31.7% of total
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-09

Shares Outstanding Growth Rate

3-Year CAGRincreasing
+28.9%
2020 → 2023
5-Year CAGRincreasing
+22.4%
2018 → 2023
10-Year CAGR—
—
—
ⓘ

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2023Latest
Diluted Shares: 4.1M
4.1M
+17.93%
FY 2022
Diluted Shares: 3.5M
3.5M
+7.07%
FY 2021
Diluted Shares: 3.3M
3.3M
+69.43%
FY 2020
Diluted Shares: 1.9M
1.9M
+18.37%
FY 2019
Diluted Shares: 1.6M
1.6M
+8.45%
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Healthcare sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Healthcare sector.

#SymbolCompanyShares (Basic)vs ASLN
#1
Merck & Co., Inc.MRK
Merck & Co., Inc.
2.502B+>999%
#2
Johnson & JohnsonJNJ
Johnson & Johnson
2.429B+>999%
#3
AbbVie Inc.ABBV
AbbVie Inc.
1.780B+>999%
#4
AstraZeneca PLCAZN
AstraZeneca PLC
1.550B+>999%
#5
UnitedHealth Group IncorporatedUNH
UnitedHealth Group Incorporated
910.0M+>999%
#6
Eli Lilly and CompanyLLY
Eli Lilly and Company
898.0M+>999%
#7
ASLAN Pharmaceuticals LimitedASLN
ASLAN Pharmaceuticals LimitedYOU
4.1M—

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

ASLAN Pharmaceuticals Limited (ASLN) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of December 31, 2023, ASLAN Pharmaceuticals Limited reports 4.1M basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

ASLAN Pharmaceuticals Limited's basic shares outstanding (4.1M) represents currently issued shares. Diluted shares outstanding (4.1M) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +0.00%.

Shares Outstanding vs. Float (Free Float)

ASLAN Pharmaceuticals Limited's float is 102.6M (31.7% of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

Float102.6M(31.7%)
Outstanding323.8M

ⓘ Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · USD

About shares outstanding & methodology

ASLAN Pharmaceuticals Limited (ASLN) shares outstanding history from 2014 to 2023. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

ASLAN Pharmaceuticals Limited shares outstanding for the fiscal year ending December 31, 2023 were 4.1M, a 17.93% increase year-over-year. ASLAN Pharmaceuticals Limited FY 2023 shares outstanding were 4.1M, a +17.93% increase from FY 2022.

ASLAN Pharmaceuticals Limited is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of — — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.
Market capSplitsEarningsFinancials (Income)Cash on handFree cash flowNet incomePrice history

Frequently asked questions

ASLN shares outstanding · 4 questions

As of December 31, 2023, ASLAN Pharmaceuticals Limited (ASLN) has approximately 4.1M basic shares outstanding and 4.1M diluted shares outstanding. This represents a +17.93% year-over-year increase from FY 2022 (3.5M). The increase may reflect equity compensation issuances or secondary offerings.

ASLN shares outstandinghow many shares does ASLN haveASLN basic shares 2023ASLN diluted shares

▸ Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · ASLAN Pharmaceuticals Limited SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-09